Israeli biopharmaceutical company developing A3AR-targeted drugs for cancer, liver, and inflammatory diseases in Phase II/III trials.
Get notified the moment Can-Fite BioPharma Ltd. (CANF) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.